What causes male breast enlargement?

Male breast enlargement (gynecomastia) occurs when hormonal imbalances, medications, or health conditions cause breast tissue growth in men. Most cases result from elevated estrogen or reduced testosterone levels, affecting up to 70% of males at some point in their lives.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Male Breast Enlargement

Male breast enlargement, medically known as gynecomastia, is a common condition where breast tissue swells in boys and men. This enlargement occurs due to an imbalance between testosterone and estrogen hormones. While many assume that men don't produce estrogen, they actually do produce small amounts, and when this delicate balance shifts, breast tissue can grow.

Gynecomastia affects between 50-70% of males at some point in their lives, with peaks during infancy, puberty, and older age. The condition can affect one or both breasts, sometimes unevenly, and ranges from a small amount of extra tissue around the nipples to more prominent breast growth. Understanding the underlying causes is crucial for proper diagnosis and treatment.

Primary Hormonal Causes

Testosterone and Estrogen Imbalance

The most fundamental cause of gynecomastia is an imbalance between testosterone and estrogen. Men naturally produce both hormones, but testosterone typically dominates. When testosterone levels drop or estrogen levels rise, breast tissue can develop. This imbalance can occur through several mechanisms: decreased testosterone production, increased conversion of testosterone to estrogen through an enzyme called aromatase, or increased sensitivity of breast tissue to normal estrogen levels.

Gynecomastia Risk and Hormone Changes by Age Group

Age-related prevalence data based on multiple epidemiological studies. Individual cases vary significantly.
Age GroupPrevalencePrimary Hormonal ChangesTypical Duration
NewbornsNewborns60-90%Maternal estrogen exposure2-3 weeks
Puberty (10-17)Puberty (10-17 years)50-60%Temporary estrogen/testosterone imbalance6 months - 2 years
Young Adults (18-30)Young Adults (18-30)10-15%Various causes, often medications or substancesVariable
Middle Age (30-50)Middle Age (30-50)20-30%Gradual testosterone decline beginsOften persistent
Older Adults (50+)Older Adults (50+)40-70%Significant testosterone decline, increased aromatizationUsually persistent

Age-related prevalence data based on multiple epidemiological studies. Individual cases vary significantly.

Regular hormone testing can help identify these imbalances early. Monitoring your testosterone, free testosterone, estradiol, and sex hormone-binding globulin (SHBG) levels provides valuable insights into your hormonal health and can help detect issues before symptoms become pronounced.

Hormonal fluctuations occur naturally at different life stages. During puberty, temporary imbalances affect up to 60% of boys, typically resolving within two years. In older men, testosterone production gradually declines after age 30, dropping about 1% per year. This age-related decrease, combined with increased body fat that converts testosterone to estrogen, makes gynecomastia more common in men over 50.

The following table shows how hormone levels and gynecomastia risk change across different age groups.

Medical Conditions That Trigger Breast Enlargement

Liver Disease

Liver disease significantly impacts hormone metabolism. The liver processes and eliminates excess hormones, particularly estrogen. When liver function declines due to cirrhosis, hepatitis, or fatty liver disease, estrogen levels can accumulate while testosterone production decreases. Additionally, liver disease often increases SHBG levels, which binds to testosterone and reduces the amount of free, active testosterone available in the body.

Thyroid Disorders

Hyperthyroidism, or an overactive thyroid, can cause gynecomastia by increasing the conversion of androgens to estrogens. Elevated thyroid hormones stimulate SHBG production, reducing free testosterone levels. Studies show that approximately 10-40% of men with hyperthyroidism develop some degree of breast enlargement. The condition typically improves once thyroid function normalizes with treatment.

Kidney Disease

Chronic kidney disease affects hormone balance through multiple pathways. Kidney dysfunction can lead to decreased testosterone production, elevated prolactin levels, and altered clearance of hormones. Men on dialysis have particularly high rates of gynecomastia, affecting up to 50% of patients. The hormonal disruptions often improve after successful kidney transplantation.

Medications and Substances

Numerous medications can cause gynecomastia as a side effect. Anti-androgens used for prostate conditions, such as finasteride and dutasteride, block the conversion of testosterone to its more potent form, DHT. Anabolic steroids, ironically used to build muscle, can convert to estrogen and cause significant breast enlargement. Other common culprits include certain antidepressants, anti-anxiety medications, heart medications like digoxin and calcium channel blockers, and stomach acid medications like cimetidine.

Recreational substances also play a significant role. Alcohol affects the liver's ability to metabolize estrogen and can directly damage testicular cells that produce testosterone. Marijuana use has been associated with gynecomastia, though the exact mechanism remains unclear. Heroin, methadone, and amphetamines can all disrupt normal hormone production and metabolism.

The table below summarizes common medications and their mechanisms for causing gynecomastia.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Lifestyle and Environmental Factors

Obesity and Body Fat Distribution

Excess body fat contributes to gynecomastia through multiple mechanisms. Fat tissue contains aromatase enzyme, which converts testosterone to estrogen. The more body fat present, the more conversion occurs. Additionally, obesity often leads to insulin resistance, which can further suppress testosterone production. Men with a BMI over 30 have significantly higher rates of breast enlargement compared to those with normal weight.

Endocrine Disruptors

Environmental chemicals known as endocrine disruptors can mimic or interfere with hormone function. Common sources include BPA in plastics, phthalates in personal care products, and pesticides in food. These chemicals can bind to estrogen receptors or interfere with testosterone production. While individual exposure levels are typically low, cumulative effects from multiple sources may contribute to hormonal imbalances.

Nutritional Deficiencies

Malnutrition and specific nutrient deficiencies can trigger gynecomastia. When the body experiences starvation or severe caloric restriction, testosterone levels plummet while relative estrogen levels remain stable or increase. This phenomenon was historically observed in prisoners of war who developed gynecomastia during refeeding. Deficiencies in zinc, vitamin D, and magnesium can also impair testosterone production.

Distinguishing True Gynecomastia from Pseudogynecomastia

Not all male breast enlargement is true gynecomastia. Pseudogynecomastia, or lipomastia, involves fat accumulation without actual breast gland tissue growth. The distinction is important because treatment approaches differ. True gynecomastia feels firm or rubbery and is centered under the nipple, while pseudogynecomastia feels soft and fatty throughout the breast area.

Physical examination by a healthcare provider can usually distinguish between the two conditions. In some cases, ultrasound or mammography may be needed for definitive diagnosis. Blood tests measuring hormone levels, liver function, kidney function, and thyroid hormones help identify underlying causes of true gynecomastia.

Diagnosis and Testing Approaches

Proper diagnosis of gynecomastia begins with a thorough medical history and physical examination. Your doctor will ask about medication use, substance use, family history, and symptom duration. The physical exam focuses on breast tissue characteristics, testicular examination, and signs of liver or thyroid disease.

Laboratory testing typically includes a comprehensive hormone panel measuring testosterone, estradiol, luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, and thyroid function. Additional tests may include liver and kidney function panels, and in some cases, genetic testing for conditions like Klinefelter syndrome. For those wanting to monitor their hormonal health proactively, comprehensive at-home testing can provide valuable baseline data and track changes over time.

If you're experiencing symptoms or want to understand your hormone levels better, you can also upload your existing blood test results for a detailed analysis using SiPhox Health's free upload service. This service provides personalized insights and recommendations based on your unique biomarker profile.

Treatment Options and Management

Addressing Underlying Causes

Treatment success depends on identifying and addressing the root cause. If medications are responsible, your doctor may adjust dosages or switch to alternatives. For hormonal imbalances, testosterone replacement therapy might be appropriate for men with documented low testosterone. Treating underlying conditions like hyperthyroidism or liver disease often resolves gynecomastia without additional intervention.

Medical Treatments

When gynecomastia persists despite addressing underlying causes, medical treatments may help. Selective estrogen receptor modulators (SERMs) like tamoxifen can block estrogen's effects on breast tissue. Aromatase inhibitors reduce estrogen production but are typically reserved for severe cases. These medications work best when started within the first year of symptom onset, as longstanding gynecomastia involves more fibrous tissue that doesn't respond well to medical therapy.

Surgical Options

For persistent gynecomastia causing significant distress or physical discomfort, surgery offers definitive treatment. Liposuction removes excess fatty tissue in cases of pseudogynecomastia or mixed presentations. Mastectomy removes breast gland tissue through small incisions. Many cases require a combination of both techniques for optimal cosmetic results. Surgery has high satisfaction rates but carries typical surgical risks including scarring, infection, and changes in nipple sensation.

Prevention Strategies and Lifestyle Modifications

While not all cases of gynecomastia are preventable, several strategies can reduce your risk. Maintaining a healthy weight through balanced nutrition and regular exercise helps optimize hormone balance. Limiting alcohol consumption and avoiding recreational drugs prevents substance-induced hormonal disruptions. Being aware of medication side effects and discussing alternatives with your healthcare provider when appropriate can prevent drug-induced gynecomastia.

Regular health monitoring plays a crucial role in prevention. Annual check-ups with hormone level assessments can detect imbalances early. Managing chronic conditions like diabetes, liver disease, and thyroid disorders helps maintain hormonal equilibrium. Reducing exposure to endocrine disruptors by choosing BPA-free products and organic foods when possible may also help, though more research is needed to establish definitive links.

Living with Gynecomastia: Psychological and Social Aspects

The psychological impact of gynecomastia often exceeds the physical symptoms. Men may experience embarrassment, anxiety, and depression related to their appearance. Social situations involving swimming, intimate relationships, or even wearing fitted clothing can become sources of stress. These psychological effects are valid concerns that deserve attention alongside physical treatment.

Support groups and counseling can help men cope with the emotional aspects of gynecomastia. Open communication with healthcare providers about both physical and psychological symptoms ensures comprehensive care. Remember that gynecomastia is a medical condition, not a reflection of masculinity or personal failure. With proper diagnosis and treatment, most men achieve significant improvement in both physical symptoms and quality of life.

The Path Forward: Taking Control of Your Health

Male breast enlargement has numerous potential causes, from natural hormonal fluctuations to medications and underlying health conditions. Understanding these causes empowers you to seek appropriate evaluation and treatment. Whether your gynecomastia is a temporary condition that will resolve on its own or requires medical intervention, knowledge and proactive healthcare are your best tools.

If you're experiencing breast enlargement, don't hesitate to consult with a healthcare provider. Early evaluation can identify treatable causes and prevent progression. With modern diagnostic tools and treatment options, gynecomastia is a manageable condition that shouldn't prevent you from living a full, confident life.

References

  1. Kanakis, G. A., & Nordkap, L. (2023). Gynecomastia: Clinical evaluation and management. European Journal of Endocrinology, 188(4), R41-R54.[PubMed][DOI]
  2. Swerdloff, R. S., & Ng, C. M. (2023). Gynecomastia: Etiology, Diagnosis, and Treatment. In Endotext. MDText.com, Inc.[Link][PubMed]
  3. Narula, H. S., & Carlson, H. E. (2022). Gynaecomastia: pathophysiology, diagnosis and treatment. Nature Reviews Endocrinology, 10(11), 684-698.[PubMed][DOI]
  4. Cuhaci, N., Polat, S. B., Evranos, B., Ersoy, R., & Cakir, B. (2022). Gynecomastia: Clinical evaluation and management. Indian Journal of Endocrinology and Metabolism, 18(2), 150-158.[PubMed][DOI]
  5. Dickson, G. (2021). Gynecomastia. American Family Physician, 85(7), 716-722.[Link][PubMed]
  6. Bowman, J. D., Kim, H., & Bustamante, J. J. (2022). Drug-induced gynecomastia. Pharmacotherapy, 32(12), 1123-1140.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my testosterone and estrogen levels at home?

You can test your testosterone and estrogen levels at home with SiPhox Health's Hormone Focus Program, which includes comprehensive hormone testing including total testosterone, free testosterone, estradiol, SHBG, and other key hormones that affect male breast tissue development.

Is gynecomastia always a sign of low testosterone?

No, gynecomastia isn't always caused by low testosterone. While testosterone deficiency is a common cause, the condition can also result from elevated estrogen levels, medications, liver or kidney disease, thyroid disorders, or even normal hormonal fluctuations during puberty. The key is the ratio between testosterone and estrogen rather than absolute testosterone levels alone.

Can gynecomastia go away on its own?

Yes, gynecomastia can resolve without treatment in many cases. Pubertal gynecomastia typically disappears within 6 months to 2 years. Drug-induced cases often improve after stopping the medication. However, gynecomastia lasting more than 12 months may involve fibrous tissue that's less likely to resolve spontaneously and may require medical or surgical treatment.

What's the difference between gynecomastia and chest fat?

True gynecomastia involves growth of actual breast gland tissue, which feels firm or rubbery and is typically centered under the nipple. Pseudogynecomastia or chest fat is simply fat accumulation that feels soft throughout the breast area. A physical exam by a healthcare provider can distinguish between them, and treatment approaches differ significantly.

Which medications most commonly cause male breast enlargement?

The medications most likely to cause gynecomastia include anti-androgens for prostate conditions (finasteride, dutasteride), anabolic steroids, some antidepressants and anti-anxiety medications, heart medications like digoxin and spironolactone, and stomach acid blockers like cimetidine. Always discuss potential side effects with your doctor before starting new medications.

When should I see a doctor about male breast enlargement?

See a doctor if you notice breast swelling, tenderness, or pain; if one breast is significantly larger than the other; if you feel a hard lump; or if you have nipple discharge. Also seek evaluation if breast enlargement persists for more than a few months, causes significant distress, or is accompanied by other symptoms like testicular changes or signs of liver disease.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details